http://orcid.org/0000-0002-5624-0439
About the Authors
- Thomas H. McCoy Jr.
-
Roles Writing – original draft, Writing – review & editing
* E-mail: thmccoy@partners.org
Affiliations Center for Quantitative Health, Massachusetts General Hospital, Boston, MA, United States of America, Department of Psychiatry, Harvard Medical School, Boston, MA, United States of America, Department of Medicine, Harvard Medical School, Boston, MA, United States of America
- Amelia M. Pellegrini
-
Roles Writing – original draft, Writing – review & editing
Affiliation Center for Quantitative Health, Massachusetts General Hospital, Boston, MA, United States of America
- Roy H. Perlis
-
Roles Conceptualization, Funding acquisition, Project administration, Supervision, Writing – original draft, Writing – review & editing
Affiliations Center for Quantitative Health, Massachusetts General Hospital, Boston, MA, United States of America, Department of Psychiatry, Harvard Medical School, Boston, MA, United States of America
Competing Interests
THM receives research funding from the Brain and Behavior Research Foundation, Telefonica Alfa, and NIA. RHP receives research funding from NIMH, NHLBI, NHGRI, and Telefonica Alfa. AMP has no disclosures to report. RHP holds equity in Psy Therapeutics and Outermost Therapeutics; serves on the scientific advisory board of Genomind, Psy Therapeutics, and Outermost Therapeutics; and consults to RID Ventures and Takeda. This does not alter our adherence to PLOS ONE policies on sharing data and materials.